207 related articles for article (PubMed ID: 26104764)
1. The expression of microRNA-34a is inversely correlated with c-MET and CDK6 and has a prognostic significance in lung adenocarcinoma patients.
Hong JH; Roh KS; Suh SS; Lee S; Sung SW; Park JK; Byun JH; Kang JH
Tumour Biol; 2015 Dec; 36(12):9327-37. PubMed ID: 26104764
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-409-3p functions as a tumor suppressor in human lung adenocarcinoma by targeting c-Met.
Wan L; Zhu L; Xu J; Lu B; Yang Y; Liu F; Wang Z
Cell Physiol Biochem; 2014; 34(4):1273-90. PubMed ID: 25278243
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of microRNA-7 and its Roles in the Regulation of Cisplatin Resistance in Lung Adenocarcinoma.
Cheng MW; Shen ZT; Hu GY; Luo LG
Cell Physiol Biochem; 2017; 42(2):660-672. PubMed ID: 28618418
[TBL] [Abstract][Full Text] [Related]
4. miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value.
Rapti SM; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Nov; 50(16-17):918-924. PubMed ID: 28624481
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.
Li Y; Guessous F; Zhang Y; Dipierro C; Kefas B; Johnson E; Marcinkiewicz L; Jiang J; Yang Y; Schmittgen TD; Lopes B; Schiff D; Purow B; Abounader R
Cancer Res; 2009 Oct; 69(19):7569-76. PubMed ID: 19773441
[TBL] [Abstract][Full Text] [Related]
6. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
[TBL] [Abstract][Full Text] [Related]
7. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of microRNA-34a in esophageal squamous cell carcinoma.
Lin X; Xu XY; Chen QS; Huang C
Genet Mol Res; 2015 Dec; 14(4):17684-91. PubMed ID: 26782413
[TBL] [Abstract][Full Text] [Related]
9. Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.
Tafsiri E; Darbouy M; Shadmehr MB; Zagryazhskaya A; Alizadeh J; Karimipoor M
Tumour Biol; 2015 Mar; 36(3):1603-12. PubMed ID: 25384507
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
[TBL] [Abstract][Full Text] [Related]
11. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of miR-452-5p expression in lung adenocarcinoma: A retrospective quantitative real-time polymerase chain reaction study and verification based on The Cancer Genome Atlas and Gene Expression Omnibus databases.
Gan XN; Luo J; Tang RX; Wang HL; Zhou H; Qin H; Gan TQ; Chen G
Tumour Biol; 2017 May; 39(5):1010428317705755. PubMed ID: 28488527
[TBL] [Abstract][Full Text] [Related]
14. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.
Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.
Cheng TL; Chang MY; Huang SY; Sheu CC; Kao EL; Cheng YJ; Chong IW
Chest; 2005 Sep; 128(3):1453-60. PubMed ID: 16162743
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.
Kim IH; Lee IH; Lee JE; Hong SH; Kim TJ; Lee KY; Kim YK; Kim SJ; Sung SW; Park JK; Yoo IR; Kim YS; Kim JO; Kang JH
Clin Lung Cancer; 2016 Sep; 17(5):e31-e43. PubMed ID: 26992846
[TBL] [Abstract][Full Text] [Related]
17. The association between miR-34 dysregulation and distant metastases formation in lung adenocarcinoma.
Daugaard I; Knudsen A; Kjeldsen TE; Hager H; Hansen LL
Exp Mol Pathol; 2017 Jun; 102(3):484-491. PubMed ID: 28512015
[TBL] [Abstract][Full Text] [Related]
18. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
[TBL] [Abstract][Full Text] [Related]
19. Combined Effect of Metastasis-Related MicroRNA, miR-34 and miR-124 Family, Methylation on Prognosis of Non-Small-Cell Lung Cancer.
Kim YH; Lee WK; Lee EB; Son JW; Kim DS; Park JY
Clin Lung Cancer; 2017 Jan; 18(1):e13-e20. PubMed ID: 27444357
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status.
Kim H; Yang JM; Jin Y; Jheon S; Kim K; Lee CT; Chung JH; Paik JH
Oncotarget; 2017 Jan; 8(5):8484-8498. PubMed ID: 28035073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
